WEDNESDAY, Oct. 30, 2024 -- Cell-free DNA blood tests (cf-bDNA) may be more costly and less effective for colorectal cancer (CRC) screening than other...

Nurix Therapeutics, Inc., a clinical stage biopharmaceutical company developing targeted protein modulation drugs designed to treat patients with...

Innovative research on Cell-free DNA (cfDNA) and other novel biomarkers for improved cardiac sarcoidosis and heart health outcomes.

Polyploidy is a state where a cell contains more copies of the genetic material than the usual “diploid” cell, which contains two copies....

If you don't smoke, don't start. If you smoke, quit. If you don't quit, change. That is the message of Philip Morris International (PMI), the company...

New fungal compounds show promise in treating colorectal cancer by targeting a key enzyme, according to a study.

The September 2024 quarter saw Neurizon Therapeutics receive positive interim results from the use of NUZ-001 to treat Amyotrophic Lateral ...

In a new study led by Johns Hopkins Medicine, the drug RK-33 has demonstrated promise in treating breast cancer that has spread to the bone (breast...

Researchers at the National University of Science and Technology MISIS have created a unique non-invasive nanosensor for measuring copper levels in...

Scientists believe they have found a quirky way to fight mosquito-spread diseases such as dengue, yellow fever and Zika - by turning male insects deaf...